Home | All reference

[RDF data]
Reference #10501

Resource URI: http://static.linkedct.org/resource/reference/10501
linkedct:PMid 11418315
linkedct:citation Wiseman GA, White CA, Sparks RB, Erwin WD, Podoloff DA, Lamonica D, Bartlett NL, Parker JA, Dunn WL, Spies SM, Belanger R, Witzig TE, Leigh BR. Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):181-94.
rdfs:label Reference #10501
foaf:page <http://www.ncbi.nlm.nih.gov/pubmed/11848515>
is linkedct:reference of <http://static.linkedct.org/resource/trials/NCT00475332>
linkedct:reference_id 10501 (xsd:int)
owl:sameAs <http://bio2rdf.org/pubmed:11848515>
rdf:type linkedct:reference